LOVE and 8CB Related Headlines
Go Back- Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
- Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
- Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
- Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
- Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
- CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
- Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
- Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
LOVE and 8CB Related Press Releases
Go Back- Cannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")
- Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders To Be Held Virtually On January 25th, 2024
- Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023
- Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million
- Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference
- CANARA BIOTECH INC. SECURES AN ADDITIONAL $10 MILLION IN NON-DILUTIVE CAPITAL WITH ITS LEAD CREDIT PROVIDER, BMO COMMERCIAL BANKING
- Cannara Biotech Inc. to Host Investor Webcast on May 4th, 2023
- Cannara Biotech Inc. reports Q2 2023 Financial Results with quarterly net revenues of $13 million, a 76% increase compared to Q2 2022
